Document is current

Article History

Received: 4 March 2023

Accepted: 9 March 2023

First Online: 29 March 2023

Declarations

:

: The Corresponding author would like to disclose that the NESMOS Department with which they are affiliated has received research funds from Motiva, Establishment Labs in 2017, and from GC Aesthetics in 2018 and 2020. The NESMOS Department has also received mini-implants from Establishment Labs, GC Aesthetics and Sebbin for research purposes. FSDP is a paid consultant for BellaSeno GmbH, has received reimbursements for travel/lodging expenses from ICEAG in 2015 and SCHEER-WG in 2019, 2020 and 2021, and is a member of Notified Body 0373, part of the Superior Institute of Health, which carries out CE Mark certification activities for the Italian Ministry of Health for the years 2021–22. In December 2022 received from Establishment Labs a speaker fee of 1.000 USD. They have no ownerships or investments to disclose. All other authors hereby certify that to the best of their knowledge no financial support or benefits has been received, neither by themselves directly, nor by any member of their immediate family or any individual or entity with whom or with which they may have a significant relationship from any commercial source which is related directly or indirectly to the scientific work which is reported on in the article. None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study, informed consent is not required.